References: The Aging Brain and Neurodegeneration¶
-
What Happens to the Brain in Alzheimer's Disease? - National Institute on Aging (NIH) - A clear walk through amyloid plaques, tau tangles, inflammation, and brain shrinkage. It's the best single page for picturing what goes wrong inside the Alzheimer's brain.
-
Memory Problems, Forgetfulness, and Aging - National Institute on Aging (NIH) - Compares normal age-related forgetfulness with warning signs of dementia and lists treatable causes of memory problems. Useful if someone in your family is having memory changes.
-
How Is Alzheimer's Disease Treated? - National Institute on Aging (NIH) - Summarizes symptom medicines and the anti-amyloid antibodies lecanemab and donanemab, including ARIA and MRI monitoring. Good for understanding what treatment really offers.
-
FDA Converts Novel Alzheimer's Disease Treatment to Traditional Approval - U.S. Food and Drug Administration - The FDA's July 2023 announcement for lecanemab, with the trial result and a plain explanation of ARIA and the boxed warning. Shows how a drug moves from accelerated to traditional approval.
-
FDA approves treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene - U.S. Food and Drug Administration - The FDA's April 2023 notice for tofersen, explaining its antisense mechanism and why the accelerated approval rested on neurofilament light. A real example of a biomarker shaping a drug decision.
-
Amyotrophic Lateral Sclerosis (ALS) - National Institute of Neurological Disorders and Stroke (NIH) - Covers symptoms, genetics, diagnosis, and current treatments for ALS in accessible language.
-
Huntington's Disease - National Institute of Neurological Disorders and Stroke (NIH) - Explains the CAG repeat, the 50 percent inheritance risk, symptoms, and symptom treatments. Pairs well with this chapter's genetics section.
-
18.1 Memory is Classified Based on Time Course and Type of Information Stored - OpenStax, Introduction to Behavioral Neuroscience (CC BY-NC-SA 4.0) - A free, open textbook section that connects memory systems to Alzheimer's disease and mild cognitive impairment. A good bridge between Chapter 9 and this chapter.
-
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade - Jack CR Jr and colleagues, Lancet Neurology, 2010 (free full text on PubMed Central) - The widely cited paper behind this chapter's MicroSim, proposing that amyloid becomes abnormal years before neurodegeneration and symptoms. Challenging, but the figures are worth studying.
-
Cognitive reserve in ageing and Alzheimer's disease - Yaakov Stern, Lancet Neurology, 2012 (free full text on PubMed Central) - A review explaining brain reserve and cognitive reserve and why some people with Alzheimer's brain changes stay sharp longer. Recommended for advanced readers.